EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Computational refinement and multivalent engineering of complementarity-determining region-grafted nanobodies on a humanized scaffold for retaining antiviral efficacy

Liyun Huo, Qin Qin, Tian Tian, Xing Zhang, Xiaoming He, Yuhui Cao, Tianfu Zhang, Yanqin Xu, Qiang Huang iD

Briefings in Bioinformatics · 2025

DOI: 10.1093/bib/bbaf477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Liyun Huo und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engine…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Complementarity Determining Regions, SARS-CoV-2, Protein Engineering. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Science and Technology New Star Program, Beijing Municipal Science & Technology Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, nanobody-based therapeutics have emerged as a highly effective strategy for COVID-19 treatment. However, camelid-derived nanobodies often require humanization engineering to reduce immunogenicity in clinical applications while simultaneously preserving their target-binding affinities. Here, we employed a computational and engineering approach to optimize the binding affinities of complementarity-determining region (CDR)-grafted humanized variants of the camelid-derived nanobody Nb2–67, which exhibits potent SARS-CoV-2 neutralization. By grafting the three CDR loops of Nb2–67 onto the humanized scaffold of the approved therapeutic nanobody Caplacizumab and refining the target-binding interface, we generated five nanobody variants with improved computational humanness scores. Three of these variants (Nb491, Nb273, and Nb1052) retained neutralizing activity. To further enhance their potency, we fused these variants to a self-assembling scaffold, generating three multivalent constructs with higher humanness scores. Pseudovirus assays showed that all the trivalent nanobodies exhibited picomolar neutralizing potency comparable to the original trivalent Nb2–67. Our study presents a novel computational and multivalent engineering strategy that effectively restores the antiviral efficacy of humanized CDR-grafted nanobody variants, offering a valuable approach for developing nanobody-based therapeutics against COVID-19 and other diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesComplementarity Determining RegionsSARS-CoV-2Protein EngineeringAntiviral AgentsCOVID-19 Drug TreatmentHumansAntibodies, NeutralizingCOVID-19Animals

Stichwörter der Autor:innen

CDR graftingantibody designantiviral nanobodymultivalent antibodyneutralizing antibodyprotein design

Substanzen

Single-Domain AntibodiesComplementarity Determining RegionsAntiviral AgentsAntibodies, Neutralizing

Autor:innen und Institutionen

  • State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Engineering Research Center of Industrial Microorganisms, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fud…
  • Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China.
  • ACROBiosystems Inc., Beijing 100176, China.
  • Multiscale Research Institute of Complex Systems, Fudan University, Shanghai 201203, China.

ORCID-Profile: Qiang Huang

Förderung

  • Beijing Science and Technology New Star Program
  • Beijing Municipal Science & Technology Plan
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Huo, L., Qin, Q., Tian, T., Zhang, X., He, X., Cao, Y., Zhang, T., Xu, Y., & Huang, Q. (2025). Computational refinement and multivalent engineering of complementarity-determining region-grafted nanobodies on a humanized scaffold for retaining antiviral efficacy. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf477

Vancouver

Huo L, Qin Q, Tian T, Zhang X, He X, Cao Y, et al. Computational refinement and multivalent engineering of complementarity-determining region-grafted nanobodies on a humanized scaffold for retaining antiviral efficacy. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf477

BibTeX
@article{Huo2025,
  author = {Huo, Liyun and Qin, Qin and Tian, Tian and Zhang, Xing and He, Xiaoming and Cao, Yuhui and Zhang, Tianfu and Xu, Yanqin and Huang, Qiang},
  title = {Computational refinement and multivalent engineering of complementarity-determining region-grafted nanobodies on a humanized scaffold for retaining antiviral efficacy},
  journal = {Briefings in Bioinformatics},
  year = {2025},
  doi = {10.1093/bib/bbaf477}
}
Kostenlos starten →